Capital International Sarl Abbott Laboratories Transaction History

Capital International Sarl

$3.71 Billion
Q3 2024

A detailed history of Capital International Sarl transactions in Abbott Laboratories stock. As of the latest transaction made, Capital International Sarl holds 256,419 shares of ABT stock, worth $29.3 Million. This represents 0.79% of its overall portfolio holdings.

Number of Shares

256,419

Previous 244,293 4.96%

Holding current value

$29.3 Million

Previous $25.4 Million 15.17%

% of portfolio

0.79%

Previous 0.81%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$100.07 - $118.13 $1.21 Million - $1.43 Million	12,126 Added 4.96%	256,419 $29.2 Million
Q2 2024 Aug 13, 2024	BUY	$100.73 - $112.44 $434,045 - $484,503	4,309 Added 1.8%	244,293 $25.4 Million
Q1 2024 May 14, 2024	BUY	$109.52 - $120.96 $8.38 Million - $9.25 Million	76,493 Added 46.79%	239,984 $27.3 Million
Q4 2023 Feb 13, 2024	BUY	$90.19 - $110.4 $1.19 Million - $1.46 Million	13,249 Added 8.82%	163,491 $18 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $1.06 Million - $1.28 Million	-11,129 Reduced 6.9%	150,242 $14.6 Million
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $53,413 - $59,513	-530 Reduced 0.33%	161,371 $17.6 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $9.19 Million - $10.8 Million	94,852 Added 141.47%	161,901 $16.4 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $343,166 - $402,587	3,610 Added 5.69%	67,049 $7.36 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $428,066 - $495,620	-4,424 Reduced 6.52%	63,439 $6.14 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $8.09 Million - $9.77 Million	-79,230 Reduced 53.86%	67,863 $7.37 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $703,959 - $858,432	-6,174 Reduced 4.03%	147,093 $17.4 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $3.92 Million - $4.8 Million	33,963 Added 28.47%	153,267 $21.6 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $763,539 - $844,697	-6,545 Reduced 5.2%	119,304 $14.1 Million
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $44,114 - $51,929	-417 Reduced 0.33%	125,849 $14.6 Million
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $655,216 - $771,944	6,020 Added 5.01%	126,266 $15.1 Million
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $105,840 - $115,335	1,008 Added 0.85%	120,246 $13.2 Million
Q3 2020 Nov 16, 2020	SELL	$91.64 - $111.29 $828,975 - $1.01 Million	-9,046 Reduced 7.05%	119,238 $13 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $1.16 Million - $1.48 Million	15,143 Added 13.38%	128,284 $11.7 Million
Q1 2020 May 15, 2020	BUY	$62.82 - $91.86 $3.44 Million - $5.04 Million	54,837 Added 94.05%	113,141 $8.93 Million
Q4 2019 Feb 18, 2020	BUY	$78.51 - $87.4 $2.35 Million - $2.61 Million	29,904 Added 105.3%	58,304 $5.06 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $908,424 - $985,014	-11,100 Reduced 28.1%	28,400 $2.38 Million
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $2.88 Million - $3.36 Million	39,500 New	39,500 $3.32 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Sarl, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Sarl with notifications on news.

Account

Capital International Sarl Abbott Laboratories Transaction History